A Mechanism of Drug Action Revealed by Structural Studies of Enoyl Reductase
نویسندگان
چکیده
M. Livingstone, P. Sziber, W. Quinn, Cell 37, 205 (1984); P. Drain, E. Folkers, W. Quinn, Neuron 6, 71 (1991); Z. L. Wu et al., Proc. Natl. Acad. Sci. U.S.A. 92, 220 (1995); W. Li, T. Tully, D. Kalderon, Learn. Mem. 2, 320 (1996). 3. E. Skoulakis, D. Kalderon, R. Davis, Neuron 11, 197 (1993). 4. A. Nighorn, M. Healy, R. Davis, ibid. 6, 455 (1991); P. Han, L. Levin, R. Reed, R. Davis, ibid. 9, 619 (1992). 5. M. Heisenberg, A. Borst, S. Wagner, D. Byers, J. Neurogenet. 2, 1 (1985); J. S. de Belle and M. Heisenberg, Proc. Natl. Acad. Sci. U.S.A. 93, 9875 (1996). 6. J. S. de Belle and M. Heisenberg, Science 263, 692 (1994). 7. A. Brand and N. Perrimon, Development 118, 401 (1993). 8. F. Quan, W. Wolfgang, M. Forte, Proc. Natl. Acad. Sci. U.S.A. 86, 4321 (1989); W. Wolfgang et al., J. Neurosci. 10, 1014 (1990). 9. F. Quan, L. Thomas, M. Forte, Proc. Natl. Acad. Sci. U.S.A. 88, 1898 (1991). 10. M. Simon, M. Strathmann, N. Gautam, Science 252, 802 (1991); H. Bourne, D. Sanders, F. McCormick, Nature 349, 117 (1991); W. Tang and A. Gilman, Cell 70, 869 (1992); A. Spiegel et al., in G Proteins (Molecular Biology Intelligence Unit, R. G. Landes Co., Austin, TX, 1994), pp. 19–20; E. Neer, Cell 60, 249 (1995). 11. Complementary DNAs encoding the short forms of GasWT and Gas* (9) were subcloned into pUAST (7) and used to transform flies [A. Spradling, inDrosophila: A Practical Approach, D. Roberts, Ed. (IRL Press, Oxford, 1986), pp. 75–197]. The UAS-Gas lines were verified by Msc I digestion of polymerase chain reaction–amplified Gas transgenes to detect the presence of a site found in GasWT but lacking as a result of the Q215L mutation. 12. 238Y and 201Y are described in (17) and C232 in (18). C747 shows identical expression to that of C772 (17) (24). C309 is described by J. D. Armstrong [thesis, University of Glasgow, Scotland (1995)]. The O’Kane laboratory screened 500 P-GAL4 lines to identify OK66, OK86, OK62, OK107, OK348, and OK415. 13. T. Tully and W. Quinn, J. Comp. Physiol. 157, 263 (1985); T. Tully, T. Preat, S. Boynton, M. Del Vecchio, Cell 79, 35 (1994). 14. In total, we analyzed behaviorally 16 P-GAL4 insertions that expressed to some degree in MBs. Flies with four insertions (OK66, OK86, KL65, and KL107) showed reduced learning in the absence of expression of constitutively activated Gas*, most likely because of genetic background differences. These were not tested further. Flies with eight insertions showed defects in olfactory acuity (30Y, C35, OK62, OK107, C302, OK415, and C532) or shock reactivity (C772), as transheterozygotes with UAS-Gas*. These were eliminated from further behavioral testing. Flies with the remaining four P-GAL4 insertions (201Y, 238Y, C309, and C747) showed disrupted learning but normal olfactory acuity and shock reactivity, as transheterozygotes with at least one UASGas* insertion. We characterized a total of two PGAL4 insertions (C232 and OK348) that expressed to some degree in the CC. 15. We suggest that olfactory learning results from Gsdependent convergence of the conditional stimulus (CS) and unconditional stimulus (US) in theMBs. This belief is reinforced by the observation that expression of Gas* in the CC does not affect learning. Formally, however, we cannot exclude the possibility that other sites of convergence of the CS and US contribute to the conditioned behavior, as in honeybees [M. Hammer and R. Menzel, J. Neurosci. 15, 1617 (1995)]. 16. Direct immunolocalization of transgenic Gas forms proved impossible, as endogenous Gas is expressed throughout the central nervous system (8). We have not observed any significant differences in qualitative expression between UAS-regulated insertions [see also (18) and D. Lin and C. Goodman, Neuron 13, 507 (1994)]. Thus, P-GAL4–driven reporter gene expression should reflect genuine expression patterns of Gas* under UAS regulation. 17. M. Y. Yang, J. D. Armstrong, I. Vilinsky, N. Strausfield, K. Kaiser, Neuron 15, 45 (1995). 18. K. O’Dell, J. Armstrong, M. Y. Yang, K. Kaiser, ibid., p. 55. 19. Pan-neural expression was driven by P-GAL4 1407 [generated by J. Urban and G. Technau; described in L. Luo, Y. Liao, L. Jan, Y. Jan,Genes Dev. 8, 1787 (1994)]. 20. The P-GAL4 C309 line was crossed to UAS-lacZ and UAS-lacZ;UAS-Gas* lines. Brains from the resultant progeny were dissected, and b-Gal activity was detected as described [S. T. Sweeney, K. Broadie, J. Keane, H. Niemann, C. J. O’Kane, Neuron 14, 341 (1995)]. 21. L. Levin et al., Cell 68, 479 (1992). 22. D. Cooper, N. Mons, J. Karpen, Nature 374, 421 (1995). 23. D. Clapman, Annu. Rev. Neurosci. 17, 441 (1994); W. Schreibmayer et al., Nature 380, 624 (1996). 24. K. Kaiser, unpublished data. 25. S. Boynton and T. Tully, Genetics 131, 655 (1992). 26. R. Sokal and F. Rohlf, in Biometry (Freeman, New York, 1981), pp. 229–240. 27. E. Yeh, K. Gustafson, G. Boulianne, Proc. Natl. Acad. Sci. U.S.A. 92, 7036 (1995). 28. L. Luo, T. Tully, K. White, Neuron 9, 595 (1992). 29. We thank K. Moffat, J. Keane, K. Störtkuhl, R. Greenspan, M. Yang, G. Boulianne, and A. Brand for reagents. Supported by grants from the Wellcome Trust and the Science and Engineering Research Council (GR/F94989) (to C.J.O’K.), the Human Frontiers Science program (to C.J.O’K., K.K., and M.F.), and NIH grant HD 32245 (to T.T.).
منابع مشابه
Development of 1,2,4-triazole-5-thione derivatives as potential inhibitors of enoyl acyl carrier protein reductase (InhA) in tuberculosis.
Tuberculosis (TB) ranks second, next to AIDS making it most formidable disease if the present age. One of the crucial enzymes involved in cell wall synthesis of Mycobacterium tuberculosis, InhA (enoyl acyl carrier protein reductase) has been authenticated as an effective target for anti-mycobacterial drug development. In the current work, we have developed novel derivatives of 1,2,4-triazole-5-...
متن کاملDevelopment of 1,2,4-triazole-5-thione derivatives as potential inhibitors of enoyl acyl carrier protein reductase (InhA) in tuberculosis.
Tuberculosis (TB) ranks second, next to AIDS making it most formidable disease if the present age. One of the crucial enzymes involved in cell wall synthesis of Mycobacterium tuberculosis, InhA (enoyl acyl carrier protein reductase) has been authenticated as an effective target for anti-mycobacterial drug development. In the current work, we have developed novel derivatives of 1,2,4-triazole-5-...
متن کاملA mechanism of drug action revealed by structural studies of enoyl reductase.
Enoyl reductase (ENR), an enzyme involved in fatty acid biosynthesis, is the target for antibacterial diazaborines and the front-line antituberculosis drug isoniazid. Analysis of the structures of complexes of Escherichia coli ENR with nicotinamide adenine dinucleotide and either thienodiazaborine or benzodiazaborine revealed the formation of a covalent bond between the 2' hydroxyl of the nicot...
متن کاملInvestigating the Mechanism of Action of SARS-CoV-2 Virus for Drug Designing: A Review
Coronavirus Disease 2019 (COVID-19) is a viral pneumonia emerged in December 2019 in Wuhan, China. Its cause is a new virus from the coronavirus family scientifically named Coronavirus Acute Respiratory Syndrome 2 (SARS-CoV-2). In this review study, articles published in English until March 23, 2020 on new coronavirus infection were reviewed. These articles are obtained by searching in PubMed, ...
متن کاملStructure of the Francisella tularensis enoyl-acyl carrier protein reductase (FabI) in complex with NAD(+) and triclosan.
Enoyl-acyl carrier protein reductase (FabI) catalyzes the last rate-limiting step in the elongation cycle of the fatty-acid biosynthesis pathway and has been validated as a potential antimicrobial drug target in Francisella tularensis. The development of new antibiotic therapies is important both to combat potential drug-resistant bioweapons and to address the broader societal problem of increa...
متن کاملStudies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents
Recent studies have demonstrated that submicromolar concentrations of the biocide triclosan arrest the growth of the apicomplexan parasites Plasmodium falciparum and Toxoplasma gondii and inhibit the activity of the apicomplexan enoyl acyl carrier protein reductase (ENR). The crystal structures of T. gondii and P. falciparum ENR in complex with NAD(+) and triclosan and of T. gondii ENR in an ap...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 1996